News and Trends 14 Jul 2021
EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year
The success rate for small biotechs applying for regulatory approval from the EMA has risen by over 100% since 2016,…
Orchard Therapeutics
- Latest Posts
Best in Biotech 11 Jan 2021
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies…
News and Trends 9 Sep 2019
4BIO Capital Raises €45M Fund to Invest in Advanced Therapies
The London-based life sciences investor 4BIO Capital has raised €45M in the first close of a fund to nurture companies…
News and Trends 5 Sep 2019
Orchard’s Gene Therapy Improves Children’s Motor Ability
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than six times over the target…
ADVERTISEMENT
Expert Advice 7 Aug 2019
Why Making the Jump from Pharma to Biotech Can be a Life Changing Experience
In less than two years, Orchard Therapeutics has changed from a small, relatively unknown UK biotech specializing in gene therapy…
News and Trends 30 Apr 2019
Orchard’s Gene Therapy Shows Potential in Treating Patients with Beta Thalassemia
Patients with the life-threatening blood disorder beta-thalassemia required fewer blood transfusions after receiving a gene therapy developed by the UK…
News and Trends 28 Mar 2019
Gene Therapy Exceeds Expectations in Treating Children’s Neurological Disease
A gene therapy developed by the UK company Orchard Therapeutics has greatly improved the motor symptoms of children with an…
News and Trends 25 Feb 2019
Orchard Achieves Good Survival with Cell Therapy for Rare Immune Deficiency
All 20 patients with a rare immunodeficiency disease survived for at least two years after receiving a cell therapy developed…
News and Trends 7 Dec 2018
Orchard’s Gene Therapy for Rare Immune Disease Works for Over a Year
A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function for at least a year…
News and Trends 1 Nov 2018
Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List
Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its Nasdaq IPO and is now…
ADVERTISEMENT
News and Trends 13 Aug 2018
Orchard Therapeutics Raises €132M to Develop Gene Therapies
Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from clinical testing to regulatory approval.…
News and Trends 3 May 2018
FDA Backs Gene Therapy for Fatal Neurodegenerative Childhood Disease
Orchard Therapeutics has received a fourth Rare Pediatric Disease Designation from the FDA for its gene therapy candidate for metachromatic leukodystrophy.…
News and Trends 28 Feb 2018
Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?
Rare diseases affect fewer than 1 in 2,000 people in Europe and less than 200,000 Americans at any given time.…
News and Trends 20 Dec 2017
British Gene Therapy Gets a Huge £85M Boost in Series B
Orchard Therapeutics has raised a big round of financing to gene therapy options for many rare diseases for which there…
News and Trends 18 Dec 2017
British Biotech Takes Over Development of Gene Therapy for Rare Immune Disease
Orchard Therapeutics has licensed a gene therapy for the rare genetic disorder X-linked chronic granulomatous disease (X-CGD) from the non-profit Généthon. …
News and Trends 23 Aug 2017
Update: British Biotech’s Gene Therapy for Rare ‘Bubble Baby’ Disease set on UK Fast-Track
UPDATE (23/08/2017): The UK has also prioritized OTL-101 for review as a 'Promising Innovative Medicine.' This is the first step…
ADVERTISEMENT
News and Trends 28 Feb 2017
It’s Global Rare Disease Day! What Cures is Biotech Cooking Up?
We've compiled a list of some of the latest advances of biotech in the field of rare disease to contribute…
News and Trends 29 Nov 2016
New British Partnership set to Cure Rare Diseases with Gene Therapy
Oxford BioMedica and Orchard Therapeutics are partnering up to bring gene therapy to the market and treat rare diseases for…
News and Trends 6 May 2016
Stem cell Biotech gets €26M to Start-off Gene Therapy Development for Children
Orchard Therapeutics has just been launched with a €26M investment led by a major investor. It will be developing gene…
